keyword
https://read.qxmd.com/read/38516106/risk-of-acute-kidney-injury-in-critically-ill-patients-with-covid-19-compared-with-seasonal-influenza-a-retrospective-cohort-study
#21
JOURNAL ARTICLE
Pauline Yeung Ng, April Ip, Andrew Kei-Yan Ng, Simon Wai-Ching Sin, Jasper Fuk-Woo Chan, Kelvin Kai-Wang To, Desmond Yat-Hin Yap
BACKGROUND: The SARS-CoV-2 virus can bind to angiotensin-converting enzyme 2 receptors on host renal cells and may cause acute kidney injury (AKI). The comparative risks of AKI in patients severely ill with COVID-19 and influenza A have not been examined. METHODS: This is a retrospective cohort study including patients with positive PCR results for SARS-CoV-2 or influenza A virus admitted to the intensive care units (ICUs) of 15 public hospitals in Hong Kong between 1st January 2013 and 30th April 2023...
April 2024: EClinicalMedicine
https://read.qxmd.com/read/38515213/revealing-the-role-of-spp1-macrophages-in-glioma-prognosis-and-therapeutic-targeting-by-investigating-tumor-associated-macrophage-landscape-in-grade-2-and-3-gliomas
#22
JOURNAL ARTICLE
Wenshu Tang, Cario W S Lo, Wei Ma, Annie T W Chu, Amy H Y Tong, Brian H Y Chung
BACKGROUND: Glioma is a highly heterogeneous brain tumor categorized into World Health Organization (WHO) grades 1-4 based on its malignancy. The suppressive immune microenvironment of glioma contributes significantly to unfavourable patient outcomes. However, the cellular composition and their complex interplays within the glioma environment remain poorly understood, and reliable prognostic markers remain elusive. Therefore, in-depth exploration of the tumor microenvironment (TME) and identification of predictive markers are crucial for improving the clinical management of glioma patients...
March 21, 2024: Cell & Bioscience
https://read.qxmd.com/read/38506205/reduced-chemokine-c-c-motif-ligand-1-expression-may-negatively-regulate-colorectal-cancer-progression-at-liver-metastatic-sites
#23
JOURNAL ARTICLE
Miku Iwata, Ryuma Haraguchi, Riko Kitazawa, Chihiro Ito, Kohei Ogawa, Yasutsugu Takada, Sohei Kitazawa
Colorectal cancer (CRC) liver metastasis, albeit a stage-IV disease, is completely curable by surgical resection in selected patients. In addressing the molecular basics of this phenomenon, differentially expressed genes at primary and liver metastatic sites were screened by RNA sequencing with the use of paraffin-embedded surgical specimens. Chemokine C-C motif ligand 1 (CCL1), a chemotactic factor for a ligand of the chemokine C-C motif receptor 8 (CCR8), was isolated as one of the differentially expressed genes...
April 2024: Journal of Cellular and Molecular Medicine
https://read.qxmd.com/read/38493215/axl-and-mertk-regulate-synovial-inflammation-and-are-modulated-by-il-6-inhibition-in-rheumatoid-arthritis
#24
JOURNAL ARTICLE
Alessandra Nerviani, Marie-Astrid Boutet, Giulia Maria Ghirardi, Katriona Goldmann, Elisabetta Sciacca, Felice Rivellese, Elena Pontarini, Edoardo Prediletto, Federico Abatecola, Mattia Caliste, Sara Pagani, Daniele Mauro, Mattia Bellan, Cankut Cubuk, Rachel Lau, Sarah E Church, Briana M Hudson, Frances Humby, Michele Bombardieri, Myles J Lewis, Costantino Pitzalis
The TAM tyrosine kinases, Axl and MerTK, play an important role in rheumatoid arthritis (RA). Here, using a unique synovial tissue bioresource of patients with RA matched for disease stage and treatment exposure, we assessed how Axl and MerTK relate to synovial histopathology and disease activity, and their topographical expression and longitudinal modulation by targeted treatments. We show that in treatment-naive patients, high AXL levels are associated with pauci-immune histology and low disease activity and inversely correlate with the expression levels of pro-inflammatory genes...
March 16, 2024: Nature Communications
https://read.qxmd.com/read/38491795/benralizumab-in-children-with-severe-eosinophilic-asthma-pharmacokinetics-and-long-term-safety-tate-study
#25
JOURNAL ARTICLE
H James Wedner, Takao Fujisawa, Theresa W Guilbert, Masanori Ikeda, Vinay Mehta, Jonathan S Tam, Pradeep B Lukka, Sara Asimus, Tomasz Durżyński, James Johnston, Wendy I White, Mihir Shah, Viktoria Werkström, Maria L Jison
BACKGROUND: Benralizumab is an anti-interleukin-5 receptor α monoclonal antibody approved as an add-on maintenance treatment for patients with uncontrolled severe asthma. Prior Phase 3 studies have evaluated benralizumab in patients aged ≥12 years with severe uncontrolled asthma. The TATE study evaluated the pharmacokinetics (PK), pharmacodynamics (PD), and safety of benralizumab treatment in children. METHODS: TATE was an open-label, Phase 3 study of benralizumab in children aged 6-11 years from the United States and Japan (plus participants aged 12-14 years from Japan) with severe eosinophilic asthma...
March 2024: Pediatric Allergy and Immunology
https://read.qxmd.com/read/38486995/biomimetic-gemini-nanoimmunoregulators-orchestrated-for-boosted-photoimmunotherapy-by-spatiotemporally-modulating-pd-l1-and-tumor-associated-macrophages
#26
JOURNAL ARTICLE
Honglin Huang, Ningxi Li, Xiaodan Wei, Qingzhi Li, Junhan Guo, Geng Yang, Hong Yang, Lulu Cai, Yiyao Liu, Chunhui Wu
A novel strategy of not only stimulating the immune cycle but also modulating the immunosuppressive tumor microenvironment is of vital importance to efficient cancer immunotherapy. Here, a new type of spatiotemporal biomimetic "Gemini nanoimmunoregulators" was engineered to activate robust systemic photoimmunotherapy by integrating the triple-punch of amplified immunogenic cell death (ICD), tumor-associated macrophages (TAMs) phenotype reprogramming and programmed cell death ligand 1 (PD-L1) degradation. The "Gemini nanoimmunoregulators" PM@RM-T7 and PR@RM-M2 were constructed by taking the biocompatible mesoporous polydopamine (mPDA) as nanovectors to deliver metformin (Met) and toll-like receptor 7/8 agonist resiquimod (R848) to cancer cells and TAMs by specific biorecognition via wrapping of red blood cell membrane (RM) inlaid with T7 or M2 peptides...
March 2024: Acta Pharmaceutica Sinica. B
https://read.qxmd.com/read/38479552/hypoxia-induced-trem1-promotes-mesenchymal-like-states-of-glioma-stem-cells-via-alternatively-activating-tumor-associated-macrophages
#27
JOURNAL ARTICLE
Minhai Dong, Xiaolin Zhang, Peng Peng, Zirong Chen, Yang Zhang, Lijun Wan, Wang Xiang, Guohao Liu, Yang Guo, Qungen Xiao, Baofeng Wang, Dongsheng Guo, Min Zhu, Xingjiang Yu, Feng Wan
The mesenchymal subtype of glioblastoma (GBM) cells characterized by aggressive invasion and therapeutic resistance is thought to be dependent on cell-intrinsic alteration and extrinsic cellular crosstalk. Tumor-associated macrophages (TAMs) are pivotal in tumor progression, chemo-resistance, angiogenesis, and stemness maintenance. However, the impact of TAMs on the shifts in glioma stem cells (GSCs) states remains largely uncovered. Herein, we showed that the triggering receptor expressed on myeloid cells-1 (TREM1) preferentially expressed by M2-like TAMs and induced GSCs into mesenchymal-like states by modulating the secretion of TGFβ2, which activated the TGFβR/SMAD2/3 signaling in GSCs...
March 11, 2024: Cancer Letters
https://read.qxmd.com/read/38477918/adjuvant-ovarian-function-suppression-in-premenopausal-hormone-receptor-positive-breast-cancer
#28
JOURNAL ARTICLE
Robert B Basmadjian, Sasha Lupichuk, Yuan Xu, May Lynn Quan, Winson Y Cheung, Darren R Brenner
IMPORTANCE: Few oncology studies have assessed the effectiveness of adjuvant ovarian function suppression (OFS) in observational settings for premenopausal hormone receptor-positive breast cancer. Target trial emulation is increasingly used for estimating treatment outcomes in observational cohorts. OBJECTIVES: To describe hormone therapy and OFS treatment patterns (aim 1), examine the association between adding OFS to tamoxifen (TAM) or aromatase inhibitor (AI) and survival (aim 2), and examine the association between duration of hormone treatment (TAM or AI) plus OFS (H-OFS) and survival (aim 3)...
March 4, 2024: JAMA Network Open
https://read.qxmd.com/read/38474590/adjuvant-novel-nanocarrier-based-targeted-therapy-for-lung-cancer
#29
REVIEW
Kangkan Sarma, Md Habban Akther, Irfan Ahmad, Obaid Afzal, Abdulmalik S A Altamimi, Manal A Alossaimi, Mariusz Jaremko, Abdul-Hamid Emwas, Preety Gautam
Lung cancer has the lowest survival rate due to its late-stage diagnosis, poor prognosis, and intra-tumoral heterogeneity. These factors decrease the effectiveness of treatment. They release chemokines and cytokines from the tumor microenvironment (TME). To improve the effectiveness of treatment, researchers emphasize personalized adjuvant therapies along with conventional ones. Targeted chemotherapeutic drug delivery systems and specific pathway-blocking agents using nanocarriers are a few of them. This study explored the nanocarrier roles and strategies to improve the treatment profile's effectiveness by striving for TME...
February 29, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38474108/serum-soluble-cd163-levels-as-a-prognostic-biomarker-in-patients-with-diffuse-large-b-cell-lymphoma-treated-with-chemoimmunotherapy
#30
JOURNAL ARTICLE
Aspasia Koudouna, Annita Ioanna Gkioka, Alexandros Gkiokas, Thomai M Tryfou, Mavra Papadatou, Alexandros Alexandropoulos, Vassiliki Bartzi, Nikolitsa Kafasi, Marie-Christine Kyrtsonis
The majority of patients with Diffuse Large B-cell Lymphoma (DLBCL) will respond to first-line treatment and be cured. However, the disease is heterogeneous, and biomarkers able to discriminate patients with suboptimal prognosis are needed. M2 CD163-positive tumor-associated macrophages (TAMs) were shown to be implicated in DLBCL disease activity regulation. Serum-soluble CD163 (sCD163) functions as a scavenger receptor for haptoglobin-hemoglobin complexes and is mostly expressed by monocytes and macrophages...
March 1, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38472734/anexelekto-axl-no-more-microrna-155-mir-155-controls-the-uncontrolled-in-sars-cov-2
#31
REVIEW
K I Papadopoulos, A Papadopoulou, T C Aw
AXL is the gene that encodes the Anexelekto (AXL) receptor tyrosine kinase that demonstrates significant roles in various cellular processes, including cell growth, survival, and migration. Anexelekto is a Greek word meaning excessive and uncontrolled, semantically implying the crucial involvement of AXL in cancer and immune biology, and in promoting cancer metastasis. AXL overexpression appears to drive epithelial to mesenchymal transition, tumor angiogenesis, decreased antitumor immune response, and resistance to therapeutic agents...
March 12, 2024: Human Cell
https://read.qxmd.com/read/38469292/an-unappreciated-cell-survival-independent-role-for-baff-initiating-chronic-lymphocytic-leukemia
#32
JOURNAL ARTICLE
Md Ashik Ullah, Beatriz Garcillán, Eden Whitlock, William A Figgett, Simona Infantino, Mahya Eslami, SiLing Yang, M Arifur Rahman, Yong H Sheng, Nicholas Weber, Pascal Schneider, Constantine S Tam, Fabienne Mackay
BACKGROUND: Chronic Lymphocytic Leukemia (CLL) is characterized by the expansion of CD19+ CD5+ B cells but its origin remains debated. Mutated CLL may originate from post-germinal center B cells and unmutated CLL from CD5+ mature B cell precursors. Irrespective of precursor types, events initiating CLL remain unknown. The cytokines BAFF and APRIL each play a significant role in CLL cell survival and accumulation, but their involvement in disease initiation remains unclear. METHODS: We generated novel CLL models lacking BAFF or APRIL...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38464205/the-ubiquitin-ligase-rbx2-sag-regulates-mitochondrial-ubiquitination-and-mitophagy
#33
Wenjuan Wang, Ermin Li, Jianqiu Zou, Qu Chen, Juan Ayala, Yuan Wen, Md Sadikul Islam, Neal L Weintraub, David J Fulton, Qiangrong Liang, Jiliang Zhou, Jinbao Liu, Jie Li, Yi Sun, Huabo Su
UNLABELLED: Clearance of damaged mitochondria via mitophagy is crucial for cellular homeostasis. While the role of ubiquitin (Ub) ligase PARKIN in mitophagy has been extensively studied, increasing evidence suggests the existence of PARKIN-independent mitophagy in highly metabolically active organs such as the heart. Here, we identify a crucial role for Cullin-RING Ub ligase 5 (CRL5) in basal mitochondrial turnover in cardiomyocytes. CRL5 is a multi-subunit Ub ligase comprised by the catalytic RING box protein RBX2 (also known as SAG), scaffold protein Cullin 5 (CUL5), and a substrate-recognizing receptor...
February 28, 2024: bioRxiv
https://read.qxmd.com/read/38460300/mgp-and-ido1-tumor-associated-macrophages-facilitate-immunoresistance-in-breast-cancer-revealed-by-single-cell-rna-sequencing
#34
JOURNAL ARTICLE
Kexin Chang, Yangchi Jiao, Bo Zhang, Lan Hou, Xiangmei He, Donghui Wang, Danxi Li, Ruolei Li, Zhe Wang, Pengyu Fan, Juliang Zhang
Immunotherapy is widely applied for the treatment of breast cancer, but to which some patients respond poorly or develop resistance. Therefore, the mechanism needs to be further studied. Transcriptomic data of 31 breast cancer patients treated with anti-programmed death receptor 1 (PD-1) was downloaded from the VIB-KULeuven Center for Cancer Biology to analyze the changes in myeloid cells in tumor tissues before and after immunotherapy. And 24 cell populations that may be immune-related were further identified...
March 8, 2024: International Immunopharmacology
https://read.qxmd.com/read/38458594/tumor-associated-macrophages-drive-glycolysis-through-the-il-8-stat3-glut3-signaling-pathway-in-pancreatic-cancer-progression
#35
JOURNAL ARTICLE
Ziyi Zhong, Kege Yang, Yunlong Li, Shurui Zhou, Hanming Yao, Yue Zhao, Yuzhou Huang, Jinmao Zou, Yaqing Li, Jiajia Li, Guoda Lian, Kaihong Huang, Shaojie Chen
Glycolytic metabolism is a hallmark of pancreatic ductal adenocarcinoma (PDAC), and tumor-associated stromal cells play important roles in tumor metabolism. We previously reported that tumor-associated macrophages (TAMs) facilitate PDAC progression. However, little is known about whether TAMs are involved in regulating glycolysis in PDAC. Here, we found a positive correlation between CD68+ TAM infiltration and FDG maximal standardized uptake (FDG SUVmax) on PET-CT images of PDAC. We discovered that the glycolytic gene set was prominently enriched in the high TAM infiltration group through Gene Set Enrichment Analysis using The Cancer Genome Atlas database...
March 6, 2024: Cancer Letters
https://read.qxmd.com/read/38420813/analysis-of-tlr2-in-primary-endocrine-resistant-of-breast-cancer
#36
JOURNAL ARTICLE
Yunmei Wang, Guangxi Wang, Xiang Wang, Jiao Yang, Yanwei Shen, Bin Zhao, Jin Yang
BACKGROUND: Previous clinical studies have suggested that Toll-like receptor (TLR)2 had predictive function for endocrine resistance in HER2-positive breast cancer (BCa). Nevertheless, it remains unclear whether TLR2 would relate to development of endocrine therapy resistance in triple-positive breast cancer (TPBC). METHODS: Bioinformatic analysis of TLR2 was carried out through a database. Ten tumor tissues were obtained from TPBC patients who underwent surgery, with five patients displaying primary resistance to tamoxifen (TAM) with the remaining 5 being sensitive...
February 22, 2024: Frontiers in Bioscience (Landmark Edition)
https://read.qxmd.com/read/38417530/tgf-%C3%AE-1-induced-sox18-elevation-promotes-hepatocellular-carcinoma-progression-and-metastasis-through-transcriptionally-upregulating-pd-l1-and-cxcl12
#37
JOURNAL ARTICLE
Jie Chen, Weibo Feng, Mengyu Sun, Wenjie Huang, Guodong Wang, Xilang Chen, Yue Yin, Xiaoping Chen, Bixiang Zhang, Yongzhan Nie, Daiming Fan, Kaichun Wu, Limin Xia
BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is characterized by an immune-suppressive microenvironment, which contributes to tumor progression, metastasis and immunotherapy resistance. Identification of HCC-intrinsic factors regulating immunosuppressive microenvironment is urgently needed. Here, we aimed to elucidate the role of SYR-Related High-Mobility Group Box 18 (SOX18) in inducing immunosuppression and to validate novel combination strategies for SOX18-mediated HCC progression and metastasis...
February 26, 2024: Gastroenterology
https://read.qxmd.com/read/38412664/xiap-overexpressing-inflammatory-breast-cancer-patients-have-high-infiltration-of-immunosuppressive-subsets-and-increased-tnfr1-signaling-targetable-with-birinapant
#38
JOURNAL ARTICLE
Christophe Van Berckelaer, Steven Van Laere, Seayoung Lee, Michael A Morse, Joseph Geradts, Luc Dirix, Mark Kockx, François Bertucci, Peter Van Dam, Gayathri R Devi
OBJECTIVE: To assess the expression pattern of X-linked inhibitor of apoptosis protein (XIAP), a cellular stress sensor, and delineate the associated changes in the tumor immune microenvironment (TiME) for prognostic value and new therapeutic targets in inflammatory breast cancer (IBC). METHODS: Immunohistochemistry was conducted to assess the spatial localization of immune subsets, XIAP, and PDL1 expression in IBC and non-inflammatory breast cancer (nIBC) pretreatment tumors (n = 142)...
February 26, 2024: Translational Oncology
https://read.qxmd.com/read/38409088/small-molecule-inhibitor-targeting-the-hsp70-bim-protein-protein-interaction-in-estrogen-receptor-positive-breast-cancer-overcomes-tamoxifen-resistance
#39
JOURNAL ARTICLE
Ting Song, Hong Zhang, Qicheng Zhao, Zhiyuan Hu, Ziqian Wang, Yang Song, Zhichao Zhang
INTRODUCTION: Estrogen receptor (ER) positive patients compromise about 70% of breast cancers. Tamoxifen, an antagonist of ERα66 (the classic ER), is the most effective and the standard first-line drug. However, its efficacy is limited by the development of acquired resistance. METHODS: A specific inhibitor of Hsp70-Bim protein-protein interaction (PPI), S1g-2, together with an inhibitor of Hsp70-Bag3 PPI, MKT-077 and an ATP-competitive inhibitor VER155008, were used as chemical tools...
February 26, 2024: Breast Cancer Research: BCR
https://read.qxmd.com/read/38407042/intracellular-magnetic-hyperthermia-enables-concurrent-down-regulation-of-cd47-and-sirp%C3%AE-to-potentiate-antitumor-immunity
#40
JOURNAL ARTICLE
Siyao Wang, Wangbo Jiao, Bin Yan, Xiaofei Liu, Qianqian Tang, Yihan Zhang, Chen Liang, Xun Wang, Yi Lyu, Haiming Fan, Xiaoli Liu
Harnessing the potential of tumor-associated macrophages (TAMs) to engulf tumor cells offers promising avenues for cancer therapy. Targeting phagocytosis checkpoints, particularly the CD47-signal regulatory protein α (SIRPα) axis, is crucial for modulating TAM activity. However, single checkpoint inhibition has shown a limited efficacy. In this study, we demonstrate that ferrimagnetic vortex-domain iron oxide (FVIO) nanoring-mediated magnetic hyperthermia effectively suppresses the expression of CD47 protein on Hepa1-6 tumor cells and SIRPα receptor on macrophages, which disrupts CD47-SIRPα interaction...
February 26, 2024: Nano Letters
keyword
keyword
12069
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.